|
Match
|
Document |
Document Title |
|
|
US20070066568 |
Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
This invention provides: 1) a method of treating a subject suffering from, or predisposed to a kidney disease or disorder; 2) a method of treating a subject suffering from a wound, or reducing the... |
|
|
US20060039965 |
Drug delivery system for hydrophobic drugs
Compositions comprising microaggregates containing hydrophobic drugs, as well as methods for their production, are described. Such microaggregates may include micelle structures or combinations... |
|
|
US20090092683 |
Micronized Wood Preservative Formulations
The present invention provides wood preservative compositions comprising micronized particles. In one embodiment, the composition comprises dispersions of micronized metal or metal compounds. In... |
|
|
US20080113956 |
Substituted Porphyrins
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20080081781 |
Methods and compositions for the treatment of metabolic syndrome
Methods and compositions containing a berberine compound or berberine related or proto-berberine or derivative compound are provided for the prevention and treatment of metabolic and... |
|
|
US20070179124 |
Substituted Porphyrins
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20070031482 |
PDT treatment method for cellulites and cosmetic use
A photosensitizer mixture and a method of treating cellulites by means of a percutaneous application of the mixture into the area of cellulite buildup followed by light illumination are presented.... |
|
|
US20060074062 |
Substituted porphyrins
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby... |
|
|
US20050137180 |
Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
Metallotetrapyrrolic compounds having photherapeutic properties useful in photodetection and phototherapy of target issues, particularly porphyrins and azaporphyrins that including gallium in the... |
|
|
US20170143988 |
WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES
The invention provides anionic water-soluble tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) containing at least one, preferably two or three, negatively charged groups and/or... |
|
|
US20060159740 |
Hydrophobic photosensitizer formulations for photodynamic therapy
Pharmaceutical liposomal formulations for photodynamic therapy are presented, which are stable in storage as liquid formulations, comprise a hydrophobic photosensitizer and one or more synthetic... |
|
|
US20050070518 |
Reduced fluence rate PDT
The invention relates to the use of reduced fluence rate PDT to treat neovasculature, particularly choroidal neovasculature (CNV). Reduced fluence rate PDT decreases the likelihood of molecular... |
|
|
US20050025804 |
Reduction of adverse inflammation
Reduction of the likelihood of adverse inflammatory reaction to an implant or a transplant is achieved through several mechanisms including the catalysis of isomerization of peroxynitrite by a... |
|
|
US20130251641 |
Functionalized Magnetic Nanoparticles and Methods of Use Thereof
The present disclosure provides compositions comprising 2-deoxyglucose-functionalized magnetic nanoparticles. The compositions are useful in various applications, which are also provided. |
|
|
US20080113955 |
TREATMENT OF INFANT HYPERBILIRUBINEMIA USING LOW DOSAGES OF STANNSOPORFIN
Methods of treating infant hyperbilirubinemia using stannsoporfin are disclosed. The methods of the invention permit treatment of various patient populations at lower doses of stannsoporfin than... |
|
|
US20080009473 |
Pyridyl-substituted porphyrin compounds and methods of use thereof
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or... |
|
|
US20070087046 |
Use of green porphyrins to treat neovasculature in the eye
Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents,... |
|
|
US20050152960 |
Use of green porphyrins to treat neovasculature in the eye
Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents,... |
|
|
US20130122056 |
Ratiometric Combinatorial Drug Delivery
The present teachings include ratiometric combinatorial drug delivery including nanoparticles, multi-drug conjugates, pharmaceutical compositions, methods of producing such compositions and... |
|
|
US20060199792 |
Peroxynitrite decomposition catalysts and methods of use thereof
This invention provides a novel class of substituted macrocyclic metallic complexes. The complexes are useful as peroxynitrite decomposition catalysts. Pharmaceutical compositions, and methods of... |
|
|
US20050148568 |
Targeted oxidative therapeutic formulation
Pharmaceutical formulation, its method of preparation, and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as... |
|
|
US20070123503 |
Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
This invention provides antioxidant cyclic salen-metal compounds, compositions of such antioxidant cyclic salen-metal compounds having superoxide activity, catalase activity and/or peroxidase... |
|
|
US20050090481 |
Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
The present invention relates to a composition comprising a photosensitizing agent and a skin-penetration enhancer. The composition herein show improved delivery of the photosensitizer through the... |
|
|
US20140364406 |
Method Of Treating Or Preventing Pathologic Effects Of Acute Increases In Hyperglycemia And/Or Acute Increases Of Free Fatty Acid Flux
One aspect of the present invention relates to a method of treating or preventing pathologic sequelae of acute hyperglycemia and/or increased fatty acid flux in a subject. This method involves... |
|
|
US20070104683 |
Composition and methods for affecting metallocorrinoid uptake
The present invention is directed to compositions and methods for affecting metallocorrinoid uptake. The compositions and methods of the present invention are particularly useful in enhancing the... |
|
|
US20080045491 |
SURFACE SANITIZER
A non-toxic antimicrobial surface sanitizer composition comprising a water-miscible alcohol, water, a weak acid and a multivalent cation (e.g., metal ion or metal compound). The composition may... |
|
|
US20070027129 |
Water-soluble compound
A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at... |
|
|
US20050112131 |
Methods of adjuvant photodynamic therapy to enhance radiation sensitization
The present invention relates to the enhancement of radiation sensitivity by using photodynamic therapy. |
|
|
US20050085455 |
Photodynamic therapy for local adipocyte reduction
The present invention is drawn to methods and compounds for transcutaneous photodynamic therapy (“PDT”) of target adipocyte cells or adipose tissue in a mammalian subject, which includes... |
|
|
US20100331819 |
Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy
This invention relates to photodynamic therapy (PDT), more specifically PDT for atherosclerotic plaque via delivering PDT-loaded nanoparticles such as liposomes, polymersomes, micelles and... |
|
|
US20080085883 |
OXIDANT SCAVENGERS FOR TREATMENT OF DIABETES OR USE IN TRANSPLANTATION OR INDUCTION OF IMMUNE TOLERANCE
The present invention relates, in one embodiment, to a method of preventing or treating diabetes using low molecular weight antioxidants. In a further embodiment, the invention relates to a method... |
|
|
US20070238660 |
Light activated antiviral materials and devices and methods for decontaminating virus infected environments
A method of inactivating viruses, articles for inactivating viruses and methods of manufacture of such articles are disclosed. Singlet oxygen generating dyes are attached to a substrate. Upon... |
|
|
US20050244500 |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
A method for treating a posterior ocular condition so as to improve vision is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory... |
|
|
US20120014907 |
USE OF SUBSTITUTED CYANOPYRROLIDINES AND COMBINATION PREPARATIONS CONTAINING THEM FOR TREATING HYPERLIPIDEMIA AND ASSOCIATED DISEASES
Disclosed are methods and compositions for the treatment of hyperlipidemia and conditions associated therewith, such as CHD, ischemic stroke, restenosis after angioplasty, peripheral vascular... |
|
|
US20100221307 |
ANTIVIRAL AGENTS, ANTIVIRAL FIBERS AND ANTIVIRAL FIBER STRUCTURES
Provided are antiviral agents that are effective in inactivating viruses, and fiber products and fiber structures carrying these antiviral agents. The antiviral agent effectives against influenza... |
|
|
US20070059316 |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents
Provided herein are conjugates, kits, articles of manufacture and methods for detection, diagnosis and treatment by photodynamic therapy of certain undesired biological substrate targets,... |
|
|
US20070196428 |
Nitric oxide generating medical devices
Medical devices having a catalyst capable of catalyzing the generation of nitric oxide attached to the medical device and methods of treating a vascular condition using the devices are provided. |
|
|
US20060239926 |
Specific high-relaxivity compounds
The invention relates to novel compounds that are useful for the diagnosis of many pathologies, in particular cardiovascular, cancer-related and inflammatory pathologies, and to pharmaceutical... |
|
|
US20060014732 |
Use of targeted oxidative therapeutic formulation in treatment of burns
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an... |
|
|
US20170105920 |
COSMETIC METHOD USING METAL PHTHALOCYANINE DERIVATIVE
A cosmetic method for providing a moisturizing effect and anti-aging effect to the skin of a subject, includes applying to the skin a cosmetic composition containing a metal phthalocyanine... |
|
|
US20060034941 |
Organ preconditioning, arrest, protection, preservation and recovery
The present invention relates to a method for reducing electrical disturbance of a cell's resting membrane potential comprising administering an effective amount of a composition comprising an... |
|
|
US20100255045 |
COMPOSITION FOR PHOTODYNAMIC SKIN TREATMENT
The invention relates to a composition for photodynamic therapy. The composition of the invention, in the form of a gel or a cross-linked hydrogel, includes a chlorophyll photosensitising... |
|
|
US20090269418 |
Compositions and Methods for Inducing Hair Growth
Novel therapeutic methods and pharmaceutical compositions utilizing tellurium-containing compounds for inducing hair growth for the treatment of various types of alopecia and other conditions... |
|
|
US20070191330 |
Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
Polyhydroxylated aromatic compounds, and compositions containing them, are useful for the treatment of amyloidosis, especially Alzheimer's disease, and for the treatment of diseases characterized... |
|
|
US20100113386 |
N-BENZYL SUBSTITUTED PYRIDYL PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF
The present invention relates to N-Benzyl-Substituted Pyridyl Porphyrin Compounds, compositions comprising an effective amount of an N-Benzyl-Substituted Pyridyl Porphyrin Compound and methods for... |
|
|
US20070231375 |
Liposome combination and the use thereof
The present invention relates to a liposome combination, which wrapped hydrophilic drugs in water layer and wrapped hydrophobic drugs in lipid bilayer; hydrophobic drugs are photosensitizers.... |
|
|
US20060292112 |
Dendrimer-photosensitizer complexes for medical applications
A method for enhanced Photodynamic Therapy (PDT) treatments by applying dendrimer-photosensitizer complexes to bring multiple photosensitizer moieties to a treatment site is provided. The most... |
|
|
US20150224202 |
FORMULATIONS AND USES FOR MICROPARTICLE DELIVERY OF ZINC PROTOPORPHYRINS
Formulations and methods of use thereof that relate to biocompatible delivery of zinc protoporphyrin (ZnPP) are provided. In some embodiments, the ZnPP is formulated for oral delivery.... |
|
|
US20140212514 |
PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE
The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs) and/or alcohol. |
|
|
US20080096857 |
Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins
The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or... |